A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy

NCT02959151 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Hepatocellular
Pancreatic Cancer Metastatic
Colorectal Cancer Metastatic

Interventions

DRUG: CAR-T cell

Sponsor

Shanghai GeneChem Co., Ltd.

Collaborators

[object Object]